The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis
Abstract
Introduction: Idiopathic pulmonary fibrosis (IPF) is a debilitating and progressive fibrotic interstitial lung disease often resulting in death over several years. Prediction of disease course or survival remains of keen interest for clinicians and patients though a commonly used test or tool remain elusive. Areas covered: We undertook a comprehensive review of the published literature highlighting prognostic indicators and predictors of survival in IPF. Baseline and longitudinal clinical, functional, histopathologic, and radiologic findings have been extensively studied as prognostic predictors, both individually and in composite models. Recent approaches include automated quantifiable radiologic scoring, circulating biomarkers, and genetic polymorphisms or abnormalities. This review highlights individual and composite predictors and their relative utility in clinical practice and research studies. Expert opinion: There is a growing body of knowledge highlighting readily available individual and composite predictors of outcome, though none have come to the forefront for common clinical use. Recent advances include quantitative imaging analysis, circulating serologic markers, and genetic testing, which may be more standardized and less prone to lead-time bias or related complications and comorbidities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Different composite predictors of outcome have been developed in the past years; however, clinical uptake and external validation is limited.(226–232)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [227]
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654 · cited 1×
“George’s Respiratory Questionnaire (SGRQ) and UCSD-SOBQ were used to assess response to anti-fibrotic therapy in terms of dyspnea and health-related quality of life, noting little measurable improvement from placebo in the treatment arms [25,26].”
MethodDiagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103 · cited 4×
“Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease afflicting adults most commonly in their 6 or 7 decade [1,2].”
BackgroundInfluentialA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., Lee, J. S., Maher, T. M., Wells, A. U., Antoniou, K. M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0801ci · Cited by 1,444
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Ley, B., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Tomassetti, S., Lee, J. S., Poletti, V., Buccioli, M., Elicker, B. M., Jones, K. D., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00004 · Cited by 1,308
Self-citationDiagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
Lynch, D. A., Sverzellati, N., Travis, W. D., Brown, K. K., Colby, T. V., Galvin, J. R., Goldin, J. G., Hansell, D. M., Inoue, Y., Johkoh, T., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30433-2 · Cited by 1,030 · cited 2×
“years, but most recently combined international and Fleischner Society guidelines have updated a grading scale of diagnostic confidence based on radiologic morphology and distribution of findings [1,4].”
BackgroundSelf-citationPredicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Song, J. W., Hong, S.-B., Lim, C.-M., Koh, Y., & Kim, D. S. (2011) · European Respiratory Journal · doi:10.1183/09031936.00159709 · Cited by 783
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
Collard, H. R., King, T. E., Bartelson, B. B., Vourlekis, J. S., Schwarz, M. I., & Brown, K. K. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200211-1311oc · Cited by 764
Research works printed but not linked: 5
- Baddini Martinez JA, 2002, Med Sci Monit, 8, CR405
- Pouwels-Fry S, 2008, Sarcoidosis Vasc Dif, 25, 133
- Ravaglia C, 2019, Multidiscip Resp Med, 14
- Hamai K, 2016, Dis Markers, 4759040, 2016
- Sousa SR, 2019, Respir Med Case Rep, 26, 118
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Emerging roles of noncoding RNAs in idiopathic pulmonary fibrosis
Wang, H., Sun, K., Peng, H. F., Wang, Y., & Zhang, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02170-5 · Cited by 17
Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis
Whi, W., Lee, H.-H., Cho, Y. S., Lee, H., Yoo, H., Chung, M. P., & Choi, J. Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-83787-5 · Cited by 6
Biomarkers in Idiopathic Pulmonary Fibrosis
Stankovic, S. D., Stjepanović, M., & Ašanin, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100042 · Cited by 6
Polat, G., Özdemir, Ö., Ermin, S., Unat, D. S., & Üçsular, F. D. (2024) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v41i2.13779 · Cited by 5
Metadata
- Authors
- Moua, T., Lee, A. S., & Ryu, J. H.
- Affiliations
- Mayo Clinic (US)
- Mayo Clinic in Florida (US)
- Corresponding author
- Ryu, Jay H.
- Venue
- Expert Review of Respiratory Medicine
- Publisher
- Informa UK Limited
- Published
- 2019-08-26
- Volume
- 13
- Issue
- 10
- Pages
- 993-1004
- ISSN
- 1747-6348 (ISSN-L)
- 1747-6356
- OpenAlex
- W2968907713
- Cited by
- 10
- References
- 148
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 1
- FWCI
- 0.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Respiratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, prognostic factors, survival prediction, circulating biomarkers, genetic polymorphism, histopathologic findings, radiographic findings, interstitial lung disease
- MeSH terms
- Patient Reported Outcome Measures, Humans, Prognosis, Respiratory Function Tests, Disease Progression, Risk Assessment, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1080/17476348.2019.1656069
- The paper
- Moua, T., Lee, A. S., & Ryu, J. H. (2019). Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis. Expert Review of Respiratory Medicine. https://doi.org/10.1080/17476348.2019.1656069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.